292 related articles for article (PubMed ID: 21062750)
1. Keratin hypersumoylation alters filament dynamics and is a marker for human liver disease and keratin mutation.
Snider NT; Weerasinghe SV; Iñiguez-Lluhí JA; Herrmann H; Omary MB
J Biol Chem; 2011 Jan; 286(3):2273-84. PubMed ID: 21062750
[TBL] [Abstract][Full Text] [Related]
2. Keratin-8 null mice have different gallbladder and liver susceptibility to lithogenic diet-induced injury.
Tao GZ; Toivola DM; Zhong B; Michie SA; Resurreccion EZ; Tamai Y; Taketo MM; Omary MB
J Cell Sci; 2003 Nov; 116(Pt 22):4629-38. PubMed ID: 14576356
[TBL] [Abstract][Full Text] [Related]
3. Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver.
Ku NO; Strnad P; Bantel H; Omary MB
Hepatology; 2016 Sep; 64(3):966-76. PubMed ID: 26853542
[TBL] [Abstract][Full Text] [Related]
4. Keratin overexpression levels correlate with the extent of spontaneous pancreatic injury.
Toivola DM; Nakamichi I; Strnad P; Michie SA; Ghori N; Harada M; Zeh K; Oshima RG; Baribault H; Omary MB
Am J Pathol; 2008 Apr; 172(4):882-92. PubMed ID: 18349119
[TBL] [Abstract][Full Text] [Related]
5. Keratins let liver live: Mutations predispose to liver disease and crosslinking generates Mallory-Denk bodies.
Ku NO; Strnad P; Zhong BH; Tao GZ; Omary MB
Hepatology; 2007 Nov; 46(5):1639-49. PubMed ID: 17969036
[TBL] [Abstract][Full Text] [Related]
6. Keratin mutation in transgenic mice predisposes to Fas but not TNF-induced apoptosis and massive liver injury.
Ku NO; Soetikno RM; Omary MB
Hepatology; 2003 May; 37(5):1006-14. PubMed ID: 12717381
[TBL] [Abstract][Full Text] [Related]
7. Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity.
Zhong B; Strnad P; Selmi C; Invernizzi P; Tao GZ; Caleffi A; Chen M; Bianchi I; Podda M; Pietrangelo A; Gershwin ME; Omary MB
Hepatology; 2009 Aug; 50(2):546-54. PubMed ID: 19585610
[TBL] [Abstract][Full Text] [Related]
8. Keratin modifications and solubility properties in epithelial cells and in vitro.
Omary MB; Ku NO; Liao J; Price D
Subcell Biochem; 1998; 31():105-40. PubMed ID: 9932491
[TBL] [Abstract][Full Text] [Related]
9. Keratins turn over by ubiquitination in a phosphorylation-modulated fashion.
Ku NO; Omary MB
J Cell Biol; 2000 May; 149(3):547-52. PubMed ID: 10791969
[TBL] [Abstract][Full Text] [Related]
10. PKC412 normalizes mutation-related keratin filament disruption and hepatic injury in mice by promoting keratin-myosin binding.
Kwan R; Chen L; Looi K; Tao GZ; Weerasinghe SV; Snider NT; Conti MA; Adelstein RS; Xie Q; Omary MB
Hepatology; 2015 Dec; 62(6):1858-69. PubMed ID: 26126491
[TBL] [Abstract][Full Text] [Related]
11. Intermediate filament cytoskeleton of the liver in health and disease.
Strnad P; Stumptner C; Zatloukal K; Denk H
Histochem Cell Biol; 2008 Jun; 129(6):735-49. PubMed ID: 18443813
[TBL] [Abstract][Full Text] [Related]
12. Protein phosphatase inhibition in normal and keratin 8/18 assembly-incompetent mouse strains supports a functional role of keratin intermediate filaments in preserving hepatocyte integrity.
Toivola DM; Omary MB; Ku NO; Peltola O; Baribault H; Eriksson JE
Hepatology; 1998 Jul; 28(1):116-28. PubMed ID: 9657104
[TBL] [Abstract][Full Text] [Related]
13. Keratins 8 and 18 are type II acute-phase responsive genes overexpressed in human liver disease.
Guldiken N; Usachov V; Levada K; Trautwein C; Ziol M; Nahon P; Strnad P
Liver Int; 2015 Apr; 35(4):1203-12. PubMed ID: 24930437
[TBL] [Abstract][Full Text] [Related]
14. Mutation of a major keratin phosphorylation site predisposes to hepatotoxic injury in transgenic mice.
Ku NO; Michie SA; Soetikno RM; Resurreccion EZ; Broome RL; Omary MB
J Cell Biol; 1998 Dec; 143(7):2023-32. PubMed ID: 9864372
[TBL] [Abstract][Full Text] [Related]
15. Cytoskeletal keratin glycosylation protects epithelial tissue from injury.
Ku NO; Toivola DM; Strnad P; Omary MB
Nat Cell Biol; 2010 Sep; 12(9):876-85. PubMed ID: 20729838
[TBL] [Abstract][Full Text] [Related]
16. Simple epithelial keratins are dispensable for cytoprotection in two pancreatitis models.
Toivola DM; Baribault H; Magin T; Michie SA; Omary MB
Am J Physiol Gastrointest Liver Physiol; 2000 Dec; 279(6):G1343-54. PubMed ID: 11093958
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the major physiologic phosphorylation site of human keratin 19 and its role in filament organization.
Zhou X; Liao J; Hu L; Feng L; Omary MB
J Biol Chem; 1999 Apr; 274(18):12861-6. PubMed ID: 10212274
[TBL] [Abstract][Full Text] [Related]
18. Distribution of keratins in normal endothelial cells and a spectrum of vascular tumors: implications in tumor diagnosis.
Miettinen M; Fetsch JF
Hum Pathol; 2000 Sep; 31(9):1062-7. PubMed ID: 11014572
[TBL] [Abstract][Full Text] [Related]
19. Alteration in composition of keratin intermediate filaments in a model of breast cancer progression and the potential to reverse hallmarks of metastasis.
Mackinder MA; Evans CA; Chowdry J; Staton CA; Corfe BM
Cancer Biomark; 2012; 12(2):49-64. PubMed ID: 23396250
[TBL] [Abstract][Full Text] [Related]
20. Mutation of caspase-digestion sites in keratin 18 interferes with filament reorganization, and predisposes to hepatocyte necrosis and loss of membrane integrity.
Weerasinghe SV; Ku NO; Altshuler PJ; Kwan R; Omary MB
J Cell Sci; 2014 Apr; 127(Pt 7):1464-75. PubMed ID: 24463813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
